Programme

1st Day:

09:00 - 09:30 09:30 - 10:00





10:00 - 11:30
Chairs:
10:00


10:30

11:00

Thursday, 3rd April 2014

Registration Welcome
Martin Gerzabek - Rector of the University of Natural Resources and Life Sciences BOKU, Vienna
Wolfgang Schütz - Rector of the Medical University of Vienna
Alexander Van der Bellen - Commissioner for Universities,
Vienna
Keynotes
Mary Harney & Mike Comer
Arnold Caplan - Case Western Reserve University, Cleveland, United States of America:
“Adult Mesenchymal Stem Cells: The New Medicine”
Stephen Minger - GE healthcare, London, United Kingdom:
“Innovating Preclinical Drug Discovery and Human Cell Therapy”
Richard Kennedy - Queen’s University Belfast, Northern Ireland:
“Development and Validation of an Immune Gene Expression-based Biomarker that Predicts Response to DNA-Damaging Chemotherapy”
11:30 - 13:00
Chair:
Lunch & Posters
Hannes Stockinger
13:00 - 14:00
Chairs:
13:00


13:20


13:40

Technology
Renate Kunert & Hermann Katinger
Marco Metzger - Universitätsklinikum Würzburg, Fraunhofer IBG, Germany:
“Engineering of Vascularized Human Tissues”
Philipp Heher - FH Technikum Vienna/TCC, Austria:
“A Bioreactor-based 3D Culture System for Skeletal Muscle Engineering in Fibrin Scaffolds”
Gerno Schmiedeknecht - Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany:
“Challenges of Manufacturing ATMP's for Clinical Trials”
14:00 - 15:30
Chairs:
14:00


14:30

15:00

15:15

Policy - Regulatory
Bernd Jilma & Matt Moran
Martin Wisher - Senior Director, Scientific & Regulatory Affairs, SAFC/BioReliance, United Kingdom:
“Update on Global Regulation of Cell Therapy”
Ilona Reischl - AGES Vienna, Austria:
“Regulatory Up-date and Current Issues on ATMPs”
Matthew Moran - PharmaChemical, Dublin, Ireland:
“The Pharmaceutical Dilemma of Cell Therapies”
Simone Hennerbichler - ÖRK, Blutzentrale Linz, Austria:
“Meeting Regulatory Requirements in the Field of Cell and Tissue Banking - a Practical View”
15:30 - 16:00
Coffee break
16:00 - 18:30
Chairs:
16:00


16:30



17:00


17:30


17:45



18:00


18:15

Musculoskeletal & Dentistry
Iris Ribitsch & Heinz Redl
Ivan Martin - University Hospital, Basel, Switzerland:
“Nasal Chondrocytes for Cartilage Repair: Scientific Basis and Clinical Translation”
Florien Jenner - VetMedUni, Vienna, Austria:
“Differential Gene Expression: Profiling of the Intermediate and Outer Interzone Layers: Involvement of Inflammatory Pathways in Joint Development”
Pamela Yelick- Tufts University, Boston, United States of
America:
“Strategies for Whole Tooth Tissue Engineering”
Iris Ribitsch - VetMedUni, Vienna, Austria:
“Veterinary Regenerative Medicine – Clinical Patients as Potential Models for Naturally Occurring Disease”
Andreas Teuschl- FH Technikum Vienna/Competence Team, Austria:
“Ligament Regeneration Using Silk Scaffolds and Adipose Derived Stroma Cells”
Georg Feichtinger - University of Leeds, United Kingdom:
“Ultrasound-mediated Gene Transfer in Fibrin Based Matrices: Potential Use in Bone Tissue Regeneration”.
Johannes Grillari - BOKU Vienna, Austria:
“Levels of Circulating Vesicular MicroRNA-31 Increase with Age as well as in the Case of Osteoporosis and Inhibit Osteogenic Differentiation Capacity of Mesenchymal Stem Cells“

Programme

2nd Day:

08:30 - 10:30
Chairs:
08:30

09:00

09:30

10:00

Friday, 4th April 2014

Cardiology-Vascularsystem & Nephrology
Johann Wojta & Kurt Huber
Alexander Rosenkranz - Medical University, Graz, Austria:
“Cell Based Therapy in Nephrology: Between Hope and Reality”
Andreas Zeiher - University of Frankfurt, Germany:
“Key Lessons learned from Cell Therapy Clinical Trials”
Mariann Gyöngyösi - MedUniWien, Vienna, Austria:
“Survival of Stem Cells in Cardiac Cell-based Therapy”
Alfred Kocher - MedUniWien, Vienna, Austria:
“Stem Cells for Cardiac Regeneration in Mice and Men”
10:30 - 11:00
Coffee break
11:00 - 12:30
Chairs:
11:00



11:30


12:00

Cancer
Thomas Felzmann & Gerald Prager
Thomas Felzmann - MedUniWien, Vienna, Austria:
“A Randomized Clinical Trial for the Treatment of Glioblastoma Multiforme with the Individualized Dendritic Cell-Based Cancer Immunotherapy Av0113”
Dirk Strunk - Medical University, Salzburg, Austria:
“Mesenchymal Stem/Progenitor Cell Function: Beyond Regeneration”
Carmen Bunu Panaitescu - University of Medicine and Pharmacy Victor Babes, Timisoara, Romania:
“Centre for Gene and Cellular Therapies in the Treatment of Cancer (ONCOGEN) Timisoara - a Step Towards the Multidisciplinary Research in Eastern Europe”
12:30 - 14:00
Chair:
Lunch & Company Presentations
Iris Ribitsch
14:00 - 15:30
Chairs:
14:00

14:30


14:50


15:10

Derma - Neuro
Regina Grillari & Otto Doblhoff-Dier
Johann Bauer - EB-House, Salzburg, Austria:
“Stem Cell Therapies in Dermatological Diseases”
Regina Grillari - Evercyte, BOKU Vienna, Austria:
“Urine as a Non-Invasive Source of Kidney Epithelial Cells that Can Be Reprogrammed to Induced Pluripotent Stem Cells”
Christina Schuh - LBI Trauma, Vienna, Austria:
“Schwann/Schwann Cell like Cells for Peripheral Nerve Regeneration Approaches”
Michael Mildner - MedUniWien, Vienna, Austria:
“Use of PBMC-secretomes in Cutaneous Wound Healing”
15:30 - 16:00
Coffee break
16:00 - 18:00
Chairs:
16:00



16:30

17:00


17:30

Immunology
Hannes Stockinger & Michael Fischer
Michael Hudecek - Universitätsklinikum Würzburg, Germany:
“Engineering of Chimeric Antigen Receptor (CAR)-modified T Cells for Adoptive Immunotherapy of Cancer - Emerging Opportunities and Challenges”
Thomas Wekerle - MedUniWien, Vienna, Austria:
“Treg Induced Chimerism for Transplantation Tolerance”
Radek Spisek - Charles University, Prague, Czech Republic:
“Immunotherapy of the Prostate Cancer with Dendritic Cells Loaded with Immunogenic Tumor Cells”
Jaroslav Michalek - International Consortium for Cell Therapy and Immunotherapy, Cellthera, Ltd. and Masaryk University, Brno, Czech Republic:
“Treatment of Osteoarthritis with Freshly Isolated Stromal Vascular Fraction Cells from Adipose Tissue”